Revenue

electroCore posts strong Q2 growth and raises guidance, driven by a federal market focus. But as the company maps a path to profitability, a closer look reveals a race between strategic execution and a dwindling cash runway.

The software supply chain firm's Q2 results beat estimates, with cloud revenue soaring 53% as its security platform becomes essential for the AI era.

PAR Technology's Q2 results reveal soaring profitability and 19% revenue growth, prompting a raised 2026 outlook fueled by its AI-driven platform.

iRhythm's stellar Q2 results are just the start. A major acquisition and a new AI algorithm are set to reshape the cardiac monitoring landscape.

Apyx Medical's Q2 results show a 28% surge in its aesthetics unit, driven by the new AYON system. Is this strategic pivot away from OEM the key to its future?

Sprout Social's stellar Q2 profit beat isn't just a good quarter; it's a strategic overhaul. A look at its high-stakes bet on enterprise clients and AI.

Arlo Technologies smashed expectations with record revenue, fueled by a masterful pivot to recurring services that now form the core of its business.

Rigetti Computing posts a $52.6M quarterly loss but secures major partnerships and potential government funding, betting big on its long-term quantum strategy.

With nearly $1B in cash and a shrinking net loss, Janux is pushing its advanced prostate cancer drugs while its novel autoimmune therapy nears a key data reveal.

Stunning 120% revenue growth validates Senseonics' shift to in-house sales, but soaring costs and a widening net loss raise critical questions about its path to profitability.

Doximity's Q1 results reveal a company at a crossroads, sacrificing near-term profits for AI dominance. Engagement is soaring, but financials are strained.

Clipper Realty's latest earnings reveal a stark divide. Record-breaking residential rents are being overshadowed by a major commercial property default.

Outset Medical's Q2 results reveal a pivotal moment: a major HCA deal and stronger margins point to a new phase of sustainable growth in the dialysis market.

The iconic Canadian jeweler is delisting from the NYSE American. We dig into the financial pressures and strategic calculus behind this pivotal move.

Ad-tech firm Sabio Holdings secures a $1.5M loan at a staggering 25% interest. Is this a shrewd move to fuel growth or a sign of pressure in a tough market?

Beyond record revenues, Russel Metals' latest report shows a masterclass in strategy. A key acquisition is paying off big, and its performance is a bellwether for a resurgent U.S. industrial economy.

Amid looming US tariffs, PacifiCan is set to unveil new investments. Is this a short-term fix or a long-term strategy for BC's economic future?

Despite a net loss, Drilling Tools International's Q2 results show surprising strength, driven by innovative tech and robust free cash flow.

The luxury resale giant posted a record quarter and raised its 2026 forecast, but a wider GAAP loss tells a more complex story of strategic growth.

Cryoport hits a key profitability milestone, but the real story is its tightening grip on the booming gene therapy market. Is this a true turning point?